springerplus-faqs
Reports on the latest international advances in understanding and treating inflammation; Covers acute and chronic inflammation, pharmacology, cytotoxicology and among other topics; Offers papers, short articles, proceedings and more; 100% of authors who answered a survey reported that they would definitely publish or
After acceptance, we provide support so your article gains maximum impact in the scientific community and beyond. Please note that manuscript can only be submitted by an author of the manuscript and may not be submitted by a third party. Who decides whether my work will be accepted? - Peer-review policy; Want to
Journal of Inflammation welcomes research submissions on all aspects of inflammation.
Scientific Reports is an online multidisciplinary, open access journal from the publishers of Nature.
Authors of Proceedings. 1. Scope of This Document. This document constitutes Springer's guidelines for the preparation of proceedings papers. These may be stand-alone proceedings or part of a series. Here is a list of some of our main proceedings series: • Lecture Notes in Computer Science (LNCS), incl. its subseries
Inflammation Research (IR) publishes peer-reviewed papers on all aspects of inflammation and related fields including histopathology, immunological mechanisms, gene expression, mediators, experimental models, clinical investigations and the effect of drugs. Related fields are broadly defined and include for instance,
The Journal of Ophthalmic Inflammation and Infection is a peer-reviewed open access journal published under the brand SpringerOpen. It presents current SpringerOpen provides a free open access funding support service to help authors discover and apply for article processing charge funding. Visit our OA funding and
The journal Infection is a peer-reviewed forum for the presentation and discussion of clinically relevant information on infectious diseases for readers and contributors from all over the world. Articles deal with etiology, pathogenesis, diagnosis and treatment of infectious diseases in outpatient and inpatient setting.
Nobiletin-Ameliorated Lipopolysaccharide-Induced Inflammation in Acute Lung Injury by Suppression of NF-?B Pathway In Vivo and Vitro · Weifeng Li, Ruoqi Zhao, Xiumei Wang, Fang Liu, Jinmeng Zhao, Qing Yao (March 2018). Download PDF (1865KB) View Article · See all articles. Inflammation. Impact Factor 2.955

Annons

The photo has no tags

March 2018